Haemonetics Corporation: net_income
| Value | {"amount": 167679000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2024-03-31 – 2025-03-29 |
| Status | current |
| Entity | Haemonetics Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:27:23.650330+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/aa4483ae-d06b-4799-8db3-5731b92f73bb
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000313143-25-000025Retrieved: 2026-08-19T07:27:23.650330+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000313143/net-income/2025-03-29 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/aa4483ae-d06b-4799-8db3-5731b92f73bb
History
- supersedes {"amount": 167679, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0000313143-26-000074)